To The Moon
Home
News
TigerAI
Log In
Sign Up
Zanetaghx
+Follow
Posts · 77
Posts · 77
Following · 0
Following · 0
Followers · 0
Followers · 0
Zanetaghx
Zanetaghx
·
2021-12-31
Y
Top 5 SPACs of 2021
Many private companies went public in 2021, reaping the benefit of investors who sought to allocate
Top 5 SPACs of 2021
看
2.39K
回复
Comment
点赞
Like
编组 21备份 2
Share
Report
Zanetaghx
Zanetaghx
·
2021-08-29
Please like!
Sorry, this post has been deleted
看
2.29K
回复
Comment
点赞
1
编组 21备份 2
Share
Report
Zanetaghx
Zanetaghx
·
2021-08-28
Please like!
Sorry, this post has been deleted
看
2.94K
回复
1
点赞
4
编组 21备份 2
Share
Report
Zanetaghx
Zanetaghx
·
2021-07-26
Please like thanks!
Sorry, this post has been deleted
看
2.50K
回复
Comment
点赞
5
编组 21备份 2
Share
Report
Zanetaghx
Zanetaghx
·
2021-07-25
Please like!
Sorry, this post has been deleted
看
2.19K
回复
Comment
点赞
3
编组 21备份 2
Share
Report
Zanetaghx
Zanetaghx
·
2021-07-23
Please like and comment!
Sorry, this post has been deleted
看
1.88K
回复
Comment
点赞
3
编组 21备份 2
Share
Report
Zanetaghx
Zanetaghx
·
2021-07-22
Ok! Like pls
Wall Street ends higher, powered by strong earnings, economic cheer
NEW YORK, July 21 (Reuters) - Wall Street stocks posted their second straight daily gain on Wednesda
Wall Street ends higher, powered by strong earnings, economic cheer
看
2.02K
回复
Comment
点赞
5
编组 21备份 2
Share
Report
Zanetaghx
Zanetaghx
·
2021-07-22
Like and comment pleasee
Sorry, this post has been deleted
看
1.95K
回复
Comment
点赞
Like
编组 21备份 2
Share
Report
Zanetaghx
Zanetaghx
·
2021-07-21
Like and comment please
Moderna stock 'has taken on a life of its own' ahead of S&P 500 entrance
Moderna (MRNA) is set to join the S&P 500 index on Wednesday, replacing Alexion Pharmaceuticals Inc.
Moderna stock 'has taken on a life of its own' ahead of S&P 500 entrance
看
2.49K
回复
2
点赞
3
编组 21备份 2
Share
Report
Zanetaghx
Zanetaghx
·
2021-07-20
Hmmm
These Are the Best Under-the-Radar Chip Stocks to Invest in Now
Newer and smaller semiconductor companies with major growth potential are constantly emerging. As a
These Are the Best Under-the-Radar Chip Stocks to Invest in Now
看
2.21K
回复
Comment
点赞
3
编组 21备份 2
Share
Report
Load more
Most Discussed
{"i18n":{"language":"en_US"},"isCurrentUser":false,"userPageInfo":{"id":"3572924792782965","uuid":"3572924792782965","gmtCreate":1609830769449,"gmtModify":1622020754497,"name":"Zanetaghx","pinyin":"zanetaghx","introduction":"","introductionEn":null,"signature":"","avatar":"https://static.tigerbbs.com/00c8d7266d0f1b04eec7f35954d54324","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":5,"headSize":4,"tweetSize":77,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":1,"name":"萌萌虎","nameTw":"萌萌虎","represent":"呱呱坠地","factor":"评论帖子3次或发布1条主帖（非转发）","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":1,"symbols":null,"coverImage":null,"realNameVerified":"success","userBadges":[{"badgeId":"1026c425416b44e0aac28c11a0848493-3","templateUuid":"1026c425416b44e0aac28c11a0848493","name":" Tiger Idol","description":"Join the tiger community for 1500 days","bigImgUrl":"https://static.tigerbbs.com/8b40ae7da5bf081a1c84df14bf9e6367","smallImgUrl":"https://static.tigerbbs.com/f160eceddd7c284a8e1136557615cfad","grayImgUrl":"https://static.tigerbbs.com/11792805c468334a9b31c39f95a41c6a","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2025.02.14","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001},{"badgeId":"7a9f168ff73447fe856ed6c938b61789-1","templateUuid":"7a9f168ff73447fe856ed6c938b61789","name":"Knowledgeable Investor","description":"Traded more than 10 stocks","bigImgUrl":"https://static.tigerbbs.com/e74cc24115c4fbae6154ec1b1041bf47","smallImgUrl":"https://static.tigerbbs.com/d48265cbfd97c57f9048db29f22227b0","grayImgUrl":"https://static.tigerbbs.com/76c6d6898b073c77e1c537ebe9ac1c57","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1102},{"badgeId":"a83d7582f45846ffbccbce770ce65d84-1","templateUuid":"a83d7582f45846ffbccbce770ce65d84","name":"Real Trader","description":"Completed a transaction","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100},{"badgeId":"972123088c9646f7b6091ae0662215be-1","templateUuid":"972123088c9646f7b6091ae0662215be","name":"Elite Trader","description":"Total number of securities or futures transactions reached 30","bigImgUrl":"https://static.tigerbbs.com/ab0f87127c854ce3191a752d57b46edc","smallImgUrl":"https://static.tigerbbs.com/c9835ce48b8c8743566d344ac7a7ba8c","grayImgUrl":"https://static.tigerbbs.com/76754b53ce7a90019f132c1d2fbc698f","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":"60.04%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":4,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":11,"crmLevelSwitch":0,"location":null,"starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"page":1,"watchlist":null,"tweetList":[{"id":9003801700,"gmtCreate":1640918032301,"gmtModify":1676533554903,"author":{"id":"3572924792782965","authorId":"3572924792782965","name":"Zanetaghx","avatar":"https://static.tigerbbs.com/00c8d7266d0f1b04eec7f35954d54324","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3572924792782965","idStr":"3572924792782965"},"themes":[],"htmlText":"Y","listText":"Y","text":"Y","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9003801700","repostId":"1149905027","repostType":4,"repost":{"id":"1149905027","kind":"news","pubTimestamp":1640915848,"share":"https://ttm.financial/m/news/1149905027?lang=&edition=fundamental","pubTime":"2021-12-31 09:57","market":"us","language":"en","title":"Top 5 SPACs of 2021","url":"https://stock-news.laohu8.com/highlight/detail?id=1149905027","media":"TheStreet","summary":"Many private companies went public in 2021, reaping the benefit of investors who sought to allocate ","content":"<html><head></head><body><p>Many private companies went public in 2021, reaping the benefit of investors who sought to allocate their money into the public market, including ones that chose the SPAC route instead of the standard IPO strategy.</p><p>Special Purpose Acquisition Companies, or SPACs, were the preferred route for hundreds of companies. Even by March 31 there were 378 IPOs in the U.S., which is more than any entire calendar year between 2003 and 2019, said Duncan Lamont, head of strategic research unit at Schroders, a London-based asset manager.</p><p>The $139 billion that was raised by the end of March was over two and a half times the yearly average over this period and consisted of 79% of the year’s IPOs by number and 69% by value were SPACs, he said.</p><p>While the mania to go public via a SPAC later died down, on a year-to-date basis these figures are still 63% and 49%, Lamont said.</p><p>In 2020 there were 248 SPAC IPOs, but a record-breaking 602 were filed in 2021.</p><p>“2021 has obliterated that record,” he said. “The amount of money raised this year so far has also overtaken last year’s record total. The $160 billion of SPAC IPOs in 2021 is more than the total that was raised across 2003-20 combined.”</p><p>Going public has its benefits, but companies have sought to circumvent some of the perceived drawbacks of the IPO process by choosing SPACs, Lamont said.</p><p>“They give the potential for private companies to sell themselves for a higher price than in a traditional IPO, can give more certainty on pricing, can be faster (5-6 months vs 12-24 months for a traditional IPO) and can be less burdensome and hence less costly from a regulatory perspective,” he said.</p><blockquote><b>In hisYear in Review columnReal Money’s James "Rev Shark" DePorre says the broader market had a very tough go of it in 2021, but you wouldn't know it unless you do some digging.From Reddit and Diamond Hands to SPACs and a stealth bear market, it's been a wild ride. Get more of his insights and trading strategies on Real Money.</b></blockquote><p>Since a merger with a SPAC can be negotiated at a fair value, some companies opt to avoid the IPO “pop” where they are priced to “encourage a jump in the share price on the first day of trading,” Lamont said.</p><p>Another benefit of going public via a SPAC is that private companies can use forward looking statements when marketing themselves to a SPAC, “something which is particularly appealing for fast growing companies,” he said.</p><p>A traditional IPO prospectus is only allowed to report historical financials. Instead, SPAC mergers have a legal “safe harbor” from any such liability, Lamont said.</p><p>While going public as a SPAC appears to be a way to raise capital for a company easily, some investors have lost interest already. Many companies wind up losing valuation quickly.</p><p>A 2020 academic paper written by Michael Klausner, a Stanford Law professor and Michael Ohlrogge, a NYU School of Law professor, showed that most underperform the wider market after a deal is struck.</p><p>“Interestingly, they find that results are far better for ‘high quality sponsors,’ which they define to be individuals who are affiliated with a private assets fund with more than $1 billion of assets, or who have been a CEO or other senior officer at a Fortune 500 company,” Lamont said.</p><p>One indicator of waning enthusiasm for SPACs recently months is that 90% of the SPACs that listed in the U.S. in the first eight months of 2021 were trading below their IPO price by the end of the third quarter.</p><p>Here are the top five SPACs that are venture-backed and completed mergers with target companies, according to Dec. 22 data from Crunchbase.</p><p><b>1. SoFi</b></p><p><b>SPAC proceeds: $2.4 billion </b></p><p><b>SPAC valuation: $8.65 billion</b></p><p>SoFi (<b>SOFI</b>) is a fintech company that offers investing and loans, including home and student loans. The company went public after it merged with one of Chamath Palihapitiya’s SPACs.</p><p><b>2. Clover Health</b></p><p><b>SPAC proceeds: Up to $1.2 billion </b></p><p><b>SPAC valuation: $7 billion, according to the Silicon Valley Business Journal</b></p><p>Clover Health (<b>CLOV</b>) is a health insurance company for seniors that was the first VC-backed company to go public via a SPAC. The startup was acquired by Social Capital Hedosophia V, Chamath Palihapitiya’s SPAC.</p><p><b>3. BarkBox</b></p><p><b>SPAC proceeds: $454 million </b></p><p><b>SPAC valuation: $1.6 billion</b></p><p>Barkbox (<b>BARK</b>), the subscription e-commerce company that offers toys and other products for dogs merged with Northern Star Acquisition Group.</p><p><b>4. Hims and Hers Health</b></p><li><b>SPAC proceeds: $280 million</b></li><li><b>SPAC valuation: $1.6 billion, according to Forbes</b></li><li></li><p>Hims and Hers Health (<b>HIMS</b>) offers both health products for women and men and merged with SPAC company Oaktree Acquisitions Corp. The deal was among the first major VC-backed SPAC mergers to be completed in 2021, Crunchbase reported.</p><p><b>5. Billtrust</b></p><p><b>SPAC valuation: $1.3 billion</b></p><p>Billtrust, (<b>BTRS</b>) a payment-cycle management platform, merged with South Mountain Merger Corp.</p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Top 5 SPACs of 2021</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nTop 5 SPACs of 2021\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-31 09:57 GMT+8 <a href=https://www.thestreet.com/markets/ipos/top-5-spacs-of-2021?puc=yahoo&cm_ven=YAHOO><strong>TheStreet</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Many private companies went public in 2021, reaping the benefit of investors who sought to allocate their money into the public market, including ones that chose the SPAC route instead of the standard...</p>\n\n<a href=\"https://www.thestreet.com/markets/ipos/top-5-spacs-of-2021?puc=yahoo&cm_ven=YAHOO\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BARK":"The Original Bark Corp.","BTRS":"BTRS Holdings Inc.","HIMS":"Hims & Hers Health Inc.","CLOV":"Clover Health Corp","SOFI":"SoFi Technologies Inc."},"source_url":"https://www.thestreet.com/markets/ipos/top-5-spacs-of-2021?puc=yahoo&cm_ven=YAHOO","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1149905027","content_text":"Many private companies went public in 2021, reaping the benefit of investors who sought to allocate their money into the public market, including ones that chose the SPAC route instead of the standard IPO strategy.Special Purpose Acquisition Companies, or SPACs, were the preferred route for hundreds of companies. Even by March 31 there were 378 IPOs in the U.S., which is more than any entire calendar year between 2003 and 2019, said Duncan Lamont, head of strategic research unit at Schroders, a London-based asset manager.The $139 billion that was raised by the end of March was over two and a half times the yearly average over this period and consisted of 79% of the year’s IPOs by number and 69% by value were SPACs, he said.While the mania to go public via a SPAC later died down, on a year-to-date basis these figures are still 63% and 49%, Lamont said.In 2020 there were 248 SPAC IPOs, but a record-breaking 602 were filed in 2021.“2021 has obliterated that record,” he said. “The amount of money raised this year so far has also overtaken last year’s record total. The $160 billion of SPAC IPOs in 2021 is more than the total that was raised across 2003-20 combined.”Going public has its benefits, but companies have sought to circumvent some of the perceived drawbacks of the IPO process by choosing SPACs, Lamont said.“They give the potential for private companies to sell themselves for a higher price than in a traditional IPO, can give more certainty on pricing, can be faster (5-6 months vs 12-24 months for a traditional IPO) and can be less burdensome and hence less costly from a regulatory perspective,” he said.In hisYear in Review columnReal Money’s James \"Rev Shark\" DePorre says the broader market had a very tough go of it in 2021, but you wouldn't know it unless you do some digging.From Reddit and Diamond Hands to SPACs and a stealth bear market, it's been a wild ride. Get more of his insights and trading strategies on Real Money.Since a merger with a SPAC can be negotiated at a fair value, some companies opt to avoid the IPO “pop” where they are priced to “encourage a jump in the share price on the first day of trading,” Lamont said.Another benefit of going public via a SPAC is that private companies can use forward looking statements when marketing themselves to a SPAC, “something which is particularly appealing for fast growing companies,” he said.A traditional IPO prospectus is only allowed to report historical financials. Instead, SPAC mergers have a legal “safe harbor” from any such liability, Lamont said.While going public as a SPAC appears to be a way to raise capital for a company easily, some investors have lost interest already. Many companies wind up losing valuation quickly.A 2020 academic paper written by Michael Klausner, a Stanford Law professor and Michael Ohlrogge, a NYU School of Law professor, showed that most underperform the wider market after a deal is struck.“Interestingly, they find that results are far better for ‘high quality sponsors,’ which they define to be individuals who are affiliated with a private assets fund with more than $1 billion of assets, or who have been a CEO or other senior officer at a Fortune 500 company,” Lamont said.One indicator of waning enthusiasm for SPACs recently months is that 90% of the SPACs that listed in the U.S. in the first eight months of 2021 were trading below their IPO price by the end of the third quarter.Here are the top five SPACs that are venture-backed and completed mergers with target companies, according to Dec. 22 data from Crunchbase.1. SoFiSPAC proceeds: $2.4 billion SPAC valuation: $8.65 billionSoFi (SOFI) is a fintech company that offers investing and loans, including home and student loans. The company went public after it merged with one of Chamath Palihapitiya’s SPACs.2. Clover HealthSPAC proceeds: Up to $1.2 billion SPAC valuation: $7 billion, according to the Silicon Valley Business JournalClover Health (CLOV) is a health insurance company for seniors that was the first VC-backed company to go public via a SPAC. The startup was acquired by Social Capital Hedosophia V, Chamath Palihapitiya’s SPAC.3. BarkBoxSPAC proceeds: $454 million SPAC valuation: $1.6 billionBarkbox (BARK), the subscription e-commerce company that offers toys and other products for dogs merged with Northern Star Acquisition Group.4. Hims and Hers HealthSPAC proceeds: $280 millionSPAC valuation: $1.6 billion, according to ForbesHims and Hers Health (HIMS) offers both health products for women and men and merged with SPAC company Oaktree Acquisitions Corp. The deal was among the first major VC-backed SPAC mergers to be completed in 2021, Crunchbase reported.5. BilltrustSPAC valuation: $1.3 billionBilltrust, (BTRS) a payment-cycle management platform, merged with South Mountain Merger Corp.","news_type":1,"symbols_score_info":{"SOFI":0.9,"BARK":0.9,"CLOV":0.9,"HIMS":0.9,"BTRS":0.9}},"isVote":1,"tweetType":1,"viewCount":2394,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":813580045,"gmtCreate":1630213959287,"gmtModify":1676530245263,"author":{"id":"3572924792782965","authorId":"3572924792782965","name":"Zanetaghx","avatar":"https://static.tigerbbs.com/00c8d7266d0f1b04eec7f35954d54324","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3572924792782965","idStr":"3572924792782965"},"themes":[],"htmlText":"Please like!","listText":"Please like!","text":"Please like!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/813580045","repostId":"2162733980","repostType":4,"isVote":1,"tweetType":1,"viewCount":2290,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":813019891,"gmtCreate":1630113290113,"gmtModify":1676530227189,"author":{"id":"3572924792782965","authorId":"3572924792782965","name":"Zanetaghx","avatar":"https://static.tigerbbs.com/00c8d7266d0f1b04eec7f35954d54324","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3572924792782965","idStr":"3572924792782965"},"themes":[],"htmlText":"Please like!","listText":"Please like!","text":"Please like!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/813019891","repostId":"2162024053","repostType":4,"isVote":1,"tweetType":1,"viewCount":2944,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":800331195,"gmtCreate":1627276659117,"gmtModify":1703486561264,"author":{"id":"3572924792782965","authorId":"3572924792782965","name":"Zanetaghx","avatar":"https://static.tigerbbs.com/00c8d7266d0f1b04eec7f35954d54324","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3572924792782965","idStr":"3572924792782965"},"themes":[],"htmlText":"Please like thanks!","listText":"Please like thanks!","text":"Please like thanks!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/800331195","repostId":"1100772026","repostType":4,"isVote":1,"tweetType":1,"viewCount":2495,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":177229688,"gmtCreate":1627225964144,"gmtModify":1703485758511,"author":{"id":"3572924792782965","authorId":"3572924792782965","name":"Zanetaghx","avatar":"https://static.tigerbbs.com/00c8d7266d0f1b04eec7f35954d54324","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3572924792782965","idStr":"3572924792782965"},"themes":[],"htmlText":"Please like!","listText":"Please like!","text":"Please like!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/177229688","repostId":"2153936352","repostType":4,"isVote":1,"tweetType":1,"viewCount":2193,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":175255360,"gmtCreate":1627037284750,"gmtModify":1703482943239,"author":{"id":"3572924792782965","authorId":"3572924792782965","name":"Zanetaghx","avatar":"https://static.tigerbbs.com/00c8d7266d0f1b04eec7f35954d54324","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3572924792782965","idStr":"3572924792782965"},"themes":[],"htmlText":"Please like and comment!","listText":"Please like and comment!","text":"Please like and comment!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/175255360","repostId":"1164478982","repostType":4,"isVote":1,"tweetType":1,"viewCount":1878,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":172392298,"gmtCreate":1626933397214,"gmtModify":1703480859951,"author":{"id":"3572924792782965","authorId":"3572924792782965","name":"Zanetaghx","avatar":"https://static.tigerbbs.com/00c8d7266d0f1b04eec7f35954d54324","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3572924792782965","idStr":"3572924792782965"},"themes":[],"htmlText":"Ok! Like pls","listText":"Ok! Like pls","text":"Ok! Like pls","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/172392298","repostId":"2153477496","repostType":4,"repost":{"id":"2153477496","kind":"highlight","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1626899252,"share":"https://ttm.financial/m/news/2153477496?lang=&edition=fundamental","pubTime":"2021-07-22 04:27","market":"us","language":"en","title":"Wall Street ends higher, powered by strong earnings, economic cheer","url":"https://stock-news.laohu8.com/highlight/detail?id=2153477496","media":"Reuters","summary":"NEW YORK, July 21 (Reuters) - Wall Street stocks posted their second straight daily gain on Wednesda","content":"<p>NEW YORK, July 21 (Reuters) - Wall Street stocks posted their second straight daily gain on Wednesday, with robust corporate earnings and renewed optimism about the U.S. economic recovery fueling a risk-on rally.</p>\n<p>All three major U.S. stock indexes added to their previous session's advance, placing all three within 1% of their all-time closing highs.</p>\n<p>Economically sensitive smallcaps , semiconductors and financials outperformed the broader market.</p>\n<p>\"It’s a seesaw going on between great earnings and a recovering market and concerns over whether the economy is going to slow down because of the (COVID-19) Delta variant,\" said Peter Tuz, president of Chase Investment Counsel in Charlottesville, Virginia. \"But we’re seeing strong earnings with generally positive guidance, and the feeling that (the Delta variant) can be managed.\"</p>\n<p>A rebound in travel helped fuel United Airlines' revenue beat, boosting its stock by 3.8%.</p>\n<p>The S&P 1500 Airlines index gained 3.3%, while the S&P 1500 Hotels, Restaurant and Leisure index advanced 2.9%.</p>\n<p>\"Earlier in the week those stocks suffered because of renewed fears that travel will slow down and all related industries will suffer, but those fears have gone away,\" Tuz added. \"Demand is continuing as expected, I don’t think the Delta fear is causing people to change their plans.\"</p>\n<p>Benchmark U.S. Treasury yields continued their bounce from five-month lows following a weak 20-year bond auction, which benefited rate-sensitive banks.</p>\n<p>Wrangling in Washington over the passage of a bipartisan $1.2 trillion infrastructure package progressed as Senate Democrats moved toward a planned procedural vote despite Republican appeals for a delay.</p>\n<p>The Dow Jones Industrial Average rose 286.01 points, or 0.83%, to 34,798, the S&P 500 gained 35.63 points, or 0.82%, to 4,358.69 and the Nasdaq Composite added 133.08 points, or 0.92%, to 14,631.95.</p>\n<p>Of the 11 major sectors in the S&P 500, energy stocks</p>\n<p>were the big winners, jumping 3.5% with the help of surging crude prices .</p>\n<p>Second-quarter reporting season has shifted into overdrive, with 73 of the companies in the S&P 500 having posted results. Of those, 88% have beaten consensus expectations.</p>\n<p>Among the winners, Chipotle Mexican Grill jumped 11.5% after the burrito chain beat earnings estimates and forecast strong current-quarter sales growth. The stock boasted the S&P 500's largest percentage gain.</p>\n<p>Coca-Cola rose 1.3% after raising its full-year forecast.</p>\n<p>Interpuplic Group of Companies jumped 11.3% in the wake of its upbeat earnings release.</p>\n<p>Drugmaker Johnson & Johnson forecast $2.5 billion in sales from its <a href=\"https://laohu8.com/S/AONE.U\">one</a>-shot COVID vaccine this year and hiked its sales estimates. It closed up a modest 0.6%.</p>\n<p>On the losing side, Netflix Inc late Tuesday reported slowing subscriber growth, sending its shares down 3.3%, the second-largest percentage loser in the S&P 500.</p>\n<p>Harley-Davidson's second-quarter earnings release showed its turnaround plan appeared to be making progress, but the company lowered its operating income guidance due to tariffs from Europe, its second-biggest market. Its stock dropped 7.2%.</p>\n<p>Texas Instruments dipped more than 3% in extended trading following results posted after the bell.</p>\n<p>Advancing issues outnumbered declining ones on the NYSE by a 2.92-to-1 ratio; on Nasdaq, a 3.21-to-1 ratio favored advancers.</p>\n<p>The S&P 500 posted 38 new 52-week highs and no new lows; the Nasdaq Composite recorded 66 new highs and 34 new lows.</p>\n<p>Volume on U.S. exchanges was 9.13 billion shares, compared with the 10.17 billion average over the last 20 trading days.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Wall Street ends higher, powered by strong earnings, economic cheer</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWall Street ends higher, powered by strong earnings, economic cheer\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-07-22 04:27</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>NEW YORK, July 21 (Reuters) - Wall Street stocks posted their second straight daily gain on Wednesday, with robust corporate earnings and renewed optimism about the U.S. economic recovery fueling a risk-on rally.</p>\n<p>All three major U.S. stock indexes added to their previous session's advance, placing all three within 1% of their all-time closing highs.</p>\n<p>Economically sensitive smallcaps , semiconductors and financials outperformed the broader market.</p>\n<p>\"It’s a seesaw going on between great earnings and a recovering market and concerns over whether the economy is going to slow down because of the (COVID-19) Delta variant,\" said Peter Tuz, president of Chase Investment Counsel in Charlottesville, Virginia. \"But we’re seeing strong earnings with generally positive guidance, and the feeling that (the Delta variant) can be managed.\"</p>\n<p>A rebound in travel helped fuel United Airlines' revenue beat, boosting its stock by 3.8%.</p>\n<p>The S&P 1500 Airlines index gained 3.3%, while the S&P 1500 Hotels, Restaurant and Leisure index advanced 2.9%.</p>\n<p>\"Earlier in the week those stocks suffered because of renewed fears that travel will slow down and all related industries will suffer, but those fears have gone away,\" Tuz added. \"Demand is continuing as expected, I don’t think the Delta fear is causing people to change their plans.\"</p>\n<p>Benchmark U.S. Treasury yields continued their bounce from five-month lows following a weak 20-year bond auction, which benefited rate-sensitive banks.</p>\n<p>Wrangling in Washington over the passage of a bipartisan $1.2 trillion infrastructure package progressed as Senate Democrats moved toward a planned procedural vote despite Republican appeals for a delay.</p>\n<p>The Dow Jones Industrial Average rose 286.01 points, or 0.83%, to 34,798, the S&P 500 gained 35.63 points, or 0.82%, to 4,358.69 and the Nasdaq Composite added 133.08 points, or 0.92%, to 14,631.95.</p>\n<p>Of the 11 major sectors in the S&P 500, energy stocks</p>\n<p>were the big winners, jumping 3.5% with the help of surging crude prices .</p>\n<p>Second-quarter reporting season has shifted into overdrive, with 73 of the companies in the S&P 500 having posted results. Of those, 88% have beaten consensus expectations.</p>\n<p>Among the winners, Chipotle Mexican Grill jumped 11.5% after the burrito chain beat earnings estimates and forecast strong current-quarter sales growth. The stock boasted the S&P 500's largest percentage gain.</p>\n<p>Coca-Cola rose 1.3% after raising its full-year forecast.</p>\n<p>Interpuplic Group of Companies jumped 11.3% in the wake of its upbeat earnings release.</p>\n<p>Drugmaker Johnson & Johnson forecast $2.5 billion in sales from its <a href=\"https://laohu8.com/S/AONE.U\">one</a>-shot COVID vaccine this year and hiked its sales estimates. It closed up a modest 0.6%.</p>\n<p>On the losing side, Netflix Inc late Tuesday reported slowing subscriber growth, sending its shares down 3.3%, the second-largest percentage loser in the S&P 500.</p>\n<p>Harley-Davidson's second-quarter earnings release showed its turnaround plan appeared to be making progress, but the company lowered its operating income guidance due to tariffs from Europe, its second-biggest market. Its stock dropped 7.2%.</p>\n<p>Texas Instruments dipped more than 3% in extended trading following results posted after the bell.</p>\n<p>Advancing issues outnumbered declining ones on the NYSE by a 2.92-to-1 ratio; on Nasdaq, a 3.21-to-1 ratio favored advancers.</p>\n<p>The S&P 500 posted 38 new 52-week highs and no new lows; the Nasdaq Composite recorded 66 new highs and 34 new lows.</p>\n<p>Volume on U.S. exchanges was 9.13 billion shares, compared with the 10.17 billion average over the last 20 trading days.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2153477496","content_text":"NEW YORK, July 21 (Reuters) - Wall Street stocks posted their second straight daily gain on Wednesday, with robust corporate earnings and renewed optimism about the U.S. economic recovery fueling a risk-on rally.\nAll three major U.S. stock indexes added to their previous session's advance, placing all three within 1% of their all-time closing highs.\nEconomically sensitive smallcaps , semiconductors and financials outperformed the broader market.\n\"It’s a seesaw going on between great earnings and a recovering market and concerns over whether the economy is going to slow down because of the (COVID-19) Delta variant,\" said Peter Tuz, president of Chase Investment Counsel in Charlottesville, Virginia. \"But we’re seeing strong earnings with generally positive guidance, and the feeling that (the Delta variant) can be managed.\"\nA rebound in travel helped fuel United Airlines' revenue beat, boosting its stock by 3.8%.\nThe S&P 1500 Airlines index gained 3.3%, while the S&P 1500 Hotels, Restaurant and Leisure index advanced 2.9%.\n\"Earlier in the week those stocks suffered because of renewed fears that travel will slow down and all related industries will suffer, but those fears have gone away,\" Tuz added. \"Demand is continuing as expected, I don’t think the Delta fear is causing people to change their plans.\"\nBenchmark U.S. Treasury yields continued their bounce from five-month lows following a weak 20-year bond auction, which benefited rate-sensitive banks.\nWrangling in Washington over the passage of a bipartisan $1.2 trillion infrastructure package progressed as Senate Democrats moved toward a planned procedural vote despite Republican appeals for a delay.\nThe Dow Jones Industrial Average rose 286.01 points, or 0.83%, to 34,798, the S&P 500 gained 35.63 points, or 0.82%, to 4,358.69 and the Nasdaq Composite added 133.08 points, or 0.92%, to 14,631.95.\nOf the 11 major sectors in the S&P 500, energy stocks\nwere the big winners, jumping 3.5% with the help of surging crude prices .\nSecond-quarter reporting season has shifted into overdrive, with 73 of the companies in the S&P 500 having posted results. Of those, 88% have beaten consensus expectations.\nAmong the winners, Chipotle Mexican Grill jumped 11.5% after the burrito chain beat earnings estimates and forecast strong current-quarter sales growth. The stock boasted the S&P 500's largest percentage gain.\nCoca-Cola rose 1.3% after raising its full-year forecast.\nInterpuplic Group of Companies jumped 11.3% in the wake of its upbeat earnings release.\nDrugmaker Johnson & Johnson forecast $2.5 billion in sales from its one-shot COVID vaccine this year and hiked its sales estimates. It closed up a modest 0.6%.\nOn the losing side, Netflix Inc late Tuesday reported slowing subscriber growth, sending its shares down 3.3%, the second-largest percentage loser in the S&P 500.\nHarley-Davidson's second-quarter earnings release showed its turnaround plan appeared to be making progress, but the company lowered its operating income guidance due to tariffs from Europe, its second-biggest market. Its stock dropped 7.2%.\nTexas Instruments dipped more than 3% in extended trading following results posted after the bell.\nAdvancing issues outnumbered declining ones on the NYSE by a 2.92-to-1 ratio; on Nasdaq, a 3.21-to-1 ratio favored advancers.\nThe S&P 500 posted 38 new 52-week highs and no new lows; the Nasdaq Composite recorded 66 new highs and 34 new lows.\nVolume on U.S. exchanges was 9.13 billion shares, compared with the 10.17 billion average over the last 20 trading days.","news_type":1,"symbols_score_info":{}},"isVote":1,"tweetType":1,"viewCount":2019,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":172396422,"gmtCreate":1626933342266,"gmtModify":1703480858974,"author":{"id":"3572924792782965","authorId":"3572924792782965","name":"Zanetaghx","avatar":"https://static.tigerbbs.com/00c8d7266d0f1b04eec7f35954d54324","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3572924792782965","idStr":"3572924792782965"},"themes":[],"htmlText":"Like and comment pleasee","listText":"Like and comment pleasee","text":"Like and comment pleasee","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/172396422","repostId":"2153644879","repostType":4,"isVote":1,"tweetType":1,"viewCount":1951,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":178418956,"gmtCreate":1626831509375,"gmtModify":1703766011059,"author":{"id":"3572924792782965","authorId":"3572924792782965","name":"Zanetaghx","avatar":"https://static.tigerbbs.com/00c8d7266d0f1b04eec7f35954d54324","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3572924792782965","idStr":"3572924792782965"},"themes":[],"htmlText":"Like and comment please ","listText":"Like and comment please ","text":"Like and comment please","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":2,"repostSize":0,"link":"https://ttm.financial/post/178418956","repostId":"1120529749","repostType":4,"repost":{"id":"1120529749","kind":"news","pubTimestamp":1626831113,"share":"https://ttm.financial/m/news/1120529749?lang=&edition=fundamental","pubTime":"2021-07-21 09:31","market":"us","language":"en","title":"Moderna stock 'has taken on a life of its own' ahead of S&P 500 entrance","url":"https://stock-news.laohu8.com/highlight/detail?id=1120529749","media":"finance.yahoo","summary":"Moderna (MRNA) is set to join the S&P 500 index on Wednesday, replacing Alexion Pharmaceuticals Inc.","content":"<p>Moderna (MRNA) is set to join the S&P 500 index on Wednesday, replacing Alexion Pharmaceuticals Inc. (ALXN). The stock hassoaredamid the pandemic after its vaccine became instrumental in the fight against coronavirus.</p>\n<p>Moderna stock has “taken on a life of its own,” Michael Yee, Managing Director and Senior Research Analyst at Jefferies, told Yahoo Finance (video above). “It's priced in a huge amount of assumptions over the next ten years that haven't played out yet. People believe it’s the Tesla of biotech.”</p>\n<p>That the biotech firm would be so well-recognized and valued at over $113 billion was no sure bet. For those who invested early in the company, that wager paid off.</p>\n<p>\"Think about how fast they came up with nothing a year ago, and all of a sudden, they're doing $21 billion and have injected hundreds and hundreds and hundreds of millions of people with their drug safely,\" Yee said. \"That's a pretty big accomplishment.\"</p>\n<p><img src=\"https://static.tigerbbs.com/bb60075c3a90de67d77af15634fd41fa\" tg-width=\"858\" tg-height=\"588\" referrerpolicy=\"no-referrer\"></p>\n<p><b>Moderna's rise to recognition</b></p>\n<p>The Cambridge, Massachusetts-based biotech company was founded in 2010 and spent its first two years instealth modedeveloping drugs using messenger RNA (mRNA).</p>\n<p>The promise of mRNA — what Moderna calls \"the software of life\" — in pharmaceuticals has been huge. Modified mRNA teaches cells how to produce the proteins needed to fight and prevent infection. By altering the four letters in an mRNA sequence, this new class of drugs can, in theory, target a wide range of illnesses. The mRNA platform also promises to accelerate the time it takes to select, develop, and manufacture vaccines.</p>\n<p>On these high expectations, Moderna achieved a billion-dollar valuation within two years. Initially, the company focused its efforts on treatments for cancer, cardiovascular issues, and some rare diseases. However, developers were embattled with the problem of delivering mRNA to cells — too-strong doses set the body's immune system against the drug while too-weak doses proved ineffectual in fighting disease.</p>\n<p>Over time, the company shifted to pursuing vaccines, which CEO Stéphane Bancel believed would demonstrate the viability of the technology. Moderna had nine vaccines that made it to clinical trials, although none achieved liftoff.</p>\n<p>That changed when a deadly global pandemic hit, kicking off a vaccine race in the U.S. between Moderna and pharmaceutical titans like Pfizer (who also developed an mRNA vaccine in partnership with BioNTech) and Johnson & Johnson.</p>\n<p>The company's decade of research iterating on the basic science behind mRNA proved consequential in its success in developing a coronavirus vaccine in record time. On January 11, 2020, Chinese scientists revealed the genetic sequence for SARS-CoV-2. By February 24, 2020, Moderna shipped thefirst dosesof its mRNA coronavirus vaccine to the NIAID to begin phase I trials. And in December of 2020, phase III trials demonstrated 94.1% efficacy against symptomatic COVID-19. The FDA subsequently approved Moderna's vaccine for emergency use in the United States, Canada, and the European Union.</p>\n<p>Moderna's COVID-19 vaccine marks its first — and only — commercially available product. On the back of strong demand for the vaccine, the company recorded its first-everprofitable quarterin Q1.</p>\n<p>The company currently has 23 othervaccines and therapeuticsin its pipeline, including vaccines for the flu, HIV, and Cytomegalovirus (CMV), which causes birth defects in newborns, all using the same mRNA technology that has seen validation from the rollout of the COVID-19 vaccine.</p>\n<p>\"I think depending on your long-term outlook of what this company could do and all of the pipeline drugs that theoretically could come about over the next 10 years, based on those prospects, it could and should be one of the largest biotech companies in the world,\" Yee said.</p>\n<p><b>A bull market in biotech</b></p>\n<p>The biotech industry has seen a phenomenal run-up in the last several years, and any pullbacks in the last six months should be viewed in that context, Yee also noted.</p>\n<p>\"It has been one of the biggest bull markets in biotech in the last three years,\" he said, citing high valuations as well as record numbers of financings, investment, and IPOs.</p>\n<p>Going forward, Yee expects more M&A activity. \"Some of the large companies which are more mature, I think, are having some struggles. And the way they've solved that is often by buying smaller companies,\" he said. \"In the big picture, things have still been very good for biotech.\"</p>","source":"lsy1612507957220","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Moderna stock 'has taken on a life of its own' ahead of S&P 500 entrance</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nModerna stock 'has taken on a life of its own' ahead of S&P 500 entrance\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-07-21 09:31 GMT+8 <a href=https://finance.yahoo.com/news/moderna-stock-sp-500-134049499.html><strong>finance.yahoo</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Moderna (MRNA) is set to join the S&P 500 index on Wednesday, replacing Alexion Pharmaceuticals Inc. (ALXN). The stock hassoaredamid the pandemic after its vaccine became instrumental in the fight ...</p>\n\n<a href=\"https://finance.yahoo.com/news/moderna-stock-sp-500-134049499.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"ALXN":"亚力兄制药","MRNA":"Moderna, Inc."},"source_url":"https://finance.yahoo.com/news/moderna-stock-sp-500-134049499.html","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1120529749","content_text":"Moderna (MRNA) is set to join the S&P 500 index on Wednesday, replacing Alexion Pharmaceuticals Inc. (ALXN). The stock hassoaredamid the pandemic after its vaccine became instrumental in the fight against coronavirus.\nModerna stock has “taken on a life of its own,” Michael Yee, Managing Director and Senior Research Analyst at Jefferies, told Yahoo Finance (video above). “It's priced in a huge amount of assumptions over the next ten years that haven't played out yet. People believe it’s the Tesla of biotech.”\nThat the biotech firm would be so well-recognized and valued at over $113 billion was no sure bet. For those who invested early in the company, that wager paid off.\n\"Think about how fast they came up with nothing a year ago, and all of a sudden, they're doing $21 billion and have injected hundreds and hundreds and hundreds of millions of people with their drug safely,\" Yee said. \"That's a pretty big accomplishment.\"\n\nModerna's rise to recognition\nThe Cambridge, Massachusetts-based biotech company was founded in 2010 and spent its first two years instealth modedeveloping drugs using messenger RNA (mRNA).\nThe promise of mRNA — what Moderna calls \"the software of life\" — in pharmaceuticals has been huge. Modified mRNA teaches cells how to produce the proteins needed to fight and prevent infection. By altering the four letters in an mRNA sequence, this new class of drugs can, in theory, target a wide range of illnesses. The mRNA platform also promises to accelerate the time it takes to select, develop, and manufacture vaccines.\nOn these high expectations, Moderna achieved a billion-dollar valuation within two years. Initially, the company focused its efforts on treatments for cancer, cardiovascular issues, and some rare diseases. However, developers were embattled with the problem of delivering mRNA to cells — too-strong doses set the body's immune system against the drug while too-weak doses proved ineffectual in fighting disease.\nOver time, the company shifted to pursuing vaccines, which CEO Stéphane Bancel believed would demonstrate the viability of the technology. Moderna had nine vaccines that made it to clinical trials, although none achieved liftoff.\nThat changed when a deadly global pandemic hit, kicking off a vaccine race in the U.S. between Moderna and pharmaceutical titans like Pfizer (who also developed an mRNA vaccine in partnership with BioNTech) and Johnson & Johnson.\nThe company's decade of research iterating on the basic science behind mRNA proved consequential in its success in developing a coronavirus vaccine in record time. On January 11, 2020, Chinese scientists revealed the genetic sequence for SARS-CoV-2. By February 24, 2020, Moderna shipped thefirst dosesof its mRNA coronavirus vaccine to the NIAID to begin phase I trials. And in December of 2020, phase III trials demonstrated 94.1% efficacy against symptomatic COVID-19. The FDA subsequently approved Moderna's vaccine for emergency use in the United States, Canada, and the European Union.\nModerna's COVID-19 vaccine marks its first — and only — commercially available product. On the back of strong demand for the vaccine, the company recorded its first-everprofitable quarterin Q1.\nThe company currently has 23 othervaccines and therapeuticsin its pipeline, including vaccines for the flu, HIV, and Cytomegalovirus (CMV), which causes birth defects in newborns, all using the same mRNA technology that has seen validation from the rollout of the COVID-19 vaccine.\n\"I think depending on your long-term outlook of what this company could do and all of the pipeline drugs that theoretically could come about over the next 10 years, based on those prospects, it could and should be one of the largest biotech companies in the world,\" Yee said.\nA bull market in biotech\nThe biotech industry has seen a phenomenal run-up in the last several years, and any pullbacks in the last six months should be viewed in that context, Yee also noted.\n\"It has been one of the biggest bull markets in biotech in the last three years,\" he said, citing high valuations as well as record numbers of financings, investment, and IPOs.\nGoing forward, Yee expects more M&A activity. \"Some of the large companies which are more mature, I think, are having some struggles. And the way they've solved that is often by buying smaller companies,\" he said. \"In the big picture, things have still been very good for biotech.\"","news_type":1,"symbols_score_info":{"MRNA":0.9,"ALXN":0.9}},"isVote":1,"tweetType":1,"viewCount":2489,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":171762589,"gmtCreate":1626765817641,"gmtModify":1703764778603,"author":{"id":"3572924792782965","authorId":"3572924792782965","name":"Zanetaghx","avatar":"https://static.tigerbbs.com/00c8d7266d0f1b04eec7f35954d54324","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3572924792782965","idStr":"3572924792782965"},"themes":[],"htmlText":"Hmmm","listText":"Hmmm","text":"Hmmm","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/171762589","repostId":"1197330931","repostType":4,"repost":{"id":"1197330931","kind":"news","pubTimestamp":1626765188,"share":"https://ttm.financial/m/news/1197330931?lang=&edition=fundamental","pubTime":"2021-07-20 15:13","market":"us","language":"en","title":"These Are the Best Under-the-Radar Chip Stocks to Invest in Now","url":"https://stock-news.laohu8.com/highlight/detail?id=1197330931","media":"The Street","summary":"Newer and smaller semiconductor companies with major growth potential are constantly emerging.\n\nAs a","content":"<blockquote>\n Newer and smaller semiconductor companies with major growth potential are constantly emerging.\n</blockquote>\n<p>As a global semiconductor shortage affects everything from computers to the auto industry, companies likeNvidia (<b>NVDA</b>) and Advance Micro Devices (<b>AMD</b>) are on every investor’s radar. The soaring demand for the silicon chip used in countless electronic devices has propelled the shares of both companies, as well as many others, astronomically.</p>\n<p>But while soaring stock prices may make backing the big players feel like a no-brainer, the volatility of the industry means that newer or smaller companies with potential for major growth are constantly emerging. Due to the industry’s dependence on factors such as foreign supply and U.S.-China diplomacy, it is not always as simple as looking at current sales and growth to dictate long-term investing strategy.</p>\n<p>One such example would beTaiwan Semiconductor Manufacturing (<b>TSM</b>).</p>\n<p>The stock of Taiwan Semi, one of the world’s largest independent semiconductor foundries, has risen by 120% in the last year. But it may have reached peak valuation as more companies making similar products come onto the market. According to a research report from World Semiconductor Trade Statistic, the global semiconductor market is projected to grow by 19.71% to $527 billion in 2021.</p>\n<p>“I think that we're going to see a significant increase in chip manufacturing and that's going to lead to some incredible opportunities, especially in some of these ancillary players,” Quint Tatro, the chief investment officer of advisory firm Joule Financial , told TheStreet. “Companies will meet the demand and start pumping out chips like no other.”</p>\n<p>Globally, there are now more than 750 companies making semiconductors - other strong players include NXP Semiconductors (<b>NXPI</b>), Applied Materials (<b>AMAT</b>) and KLA (<b>KLAC</b>). In the United States, Intel (<b>INTC</b>) and Qualcomm (<b>QCOM</b>) have been making semiconductor technology for decades. Globally, Asia Pacific dominates with more than 60% of the world’s sales.</p>\n<p>But while the spotlight is currently on those that actually make semiconductors, ancillary products are just as necessary to ramp up manufacturing while treated like a secondary investment. According to Tatro, investors should be keeping a close eye on Axcelis Technologies(<b>ACLS</b>) -Get Report, a Massachusetts-based company from which Taiwan Semiconductor buys its manufacturing equipment. He said that the company compounded its book value at over 16% over the last five years while trading at a multiple of 15, a cheap investment given its potential for growth.</p>\n<p>“If you think of Taiwan Semiconductor’s [manufacturing plans], they’re going to need increased fabrication equipment to actually produce the semiconductors,” Tatro said. “Our belief is that we will see a ramp-up in orders for Axcelis fabrication equipment that will benefit the company greatly.”</p>\n<p>Another is the Taiwan-based mCore Technology, which specializes in the packaging that surrounds the semiconductor chips. Tatro explained that after receiving the semiconductors from Taiwan Semiconductor, Intel and Apple (<b>AAPL</b>) -Get Report, the company packages them in a way that makes them ready to enter a product like a computer. Surging demand means that the company's revenue grew 25% year over year while net income increased by almost 200%.</p>\n<p>Another option is Ultra Clean Holdings (<b>UCTT</b>), which creates tools and subsystems for the semiconductor.</p>\n<p>“Similarly to Axcelis, mCore should be an absolute benefactor from the increase in manufacturing in growing revenue,” Tatro said. “[…] They've got about 42% debt to equity so it's a little more debt than that I'd like to see but they have strong cash flows and we believe that with a forward multiple of under 11, this company is undervalued and poised for this sort of ancillary ramp-up in manufacturing.”</p>\n<p>Defiance ETFs co-founder and chief investment officer, Sylvia Jablonski, said other lesser-known names are Qorvo (<b>QRVO</b>) -Get Report, whose growth likely will be very strong as more of the wireless industry transitions to the 5G technology in which the company specializes.</p>\n<p>MaxLinear (<b>MXL</b>) -Get Report and GCP Applied Technologies (<b>GCP</b>) -Get Report are fast approaching major breakthrough in profitability while companies like Texas Instruments (<b>TXN</b>) -Get Report are valuable because they have their own foundries and will be protected from global shortages.</p>\n<p>“All of these companies make the list for me because they are pretty much in the ideal situation for constructing the basic equipment to deploy the 5G technology,” Jablonski told TheStreet.</p>\n<p>“Any company that is linked to that is going to experience healthier profit margins,” Jablonski added.</p>\n<p>Investors whose only knowledge of semiconductors comes from the current investment buzz may also consider starting out with an ETF, Jablonski advised. Along with her company’s 5G ETF (<b>FIVG</b>), VanEck Vectors Semiconductor ET (<b>SMH</b>) and iShares Semiconductor ETF (<b>SOXX</b>) include both major players and less-talked-about companies like Entegris (<b>ENTG</b>) and ASE Technology (<b>ASX</b>) .</p>\n<p>By dipping one’s toes with broad-based exposure to the industry, potential investors will be able to track the different holdings and have a better understanding of individual companies to watch out for.</p>\n<p>But overall, Jablonski said that picking the right company is less important than getting into the industry generally. The chip shortage is not going anywhere soon and, with data from the Semiconductor Industry Association showing that a finished chip can take up to 26 weeks to manufacture, the investment opportunities should remain strong for at least the next five years.</p>\n<p>\"There's been a lot of talk by (President) Biden about the 5G infrastructure package and connecting rural and urban America,” Jablonski said.</p>\n<p>“A lot of the companies that allow all that to happen are semiconductor companies. There is no machine-to-machine communication, no automation processing, no AI or any of the other massive innovations in our future without semiconductors,\" Jablonski said.</p>","source":"lsy1610613172068","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>These Are the Best Under-the-Radar Chip Stocks to Invest in Now</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nThese Are the Best Under-the-Radar Chip Stocks to Invest in Now\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-07-20 15:13 GMT+8 <a href=https://www.thestreet.com/investing/chip-semiconductor-stocks-under-the-radar-investing-axcelis><strong>The Street</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Newer and smaller semiconductor companies with major growth potential are constantly emerging.\n\nAs a global semiconductor shortage affects everything from computers to the auto industry, companies ...</p>\n\n<a href=\"https://www.thestreet.com/investing/chip-semiconductor-stocks-under-the-radar-investing-axcelis\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"ACLS":"Axcelis科技设计公司","NXPI":"恩智浦","ENTG":"英特格","AMAT":"应用材料","FIVG":"Defiance Next Gen Connectivity ETF","MXL":"MaxLinear","TSM":"台积电","QRVO":"Qorvo, Inc.","QCOM":"高通","ASX":"日月光半导体","INTC":"英特尔","UCTT":"超科林半导体","SOXX":"iShares费城交易所半导体ETF","TXN":"德州仪器","KLAC":"科磊","SMH":"半导体指数ETF-HOLDRs"},"source_url":"https://www.thestreet.com/investing/chip-semiconductor-stocks-under-the-radar-investing-axcelis","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1197330931","content_text":"Newer and smaller semiconductor companies with major growth potential are constantly emerging.\n\nAs a global semiconductor shortage affects everything from computers to the auto industry, companies likeNvidia (NVDA) and Advance Micro Devices (AMD) are on every investor’s radar. The soaring demand for the silicon chip used in countless electronic devices has propelled the shares of both companies, as well as many others, astronomically.\nBut while soaring stock prices may make backing the big players feel like a no-brainer, the volatility of the industry means that newer or smaller companies with potential for major growth are constantly emerging. Due to the industry’s dependence on factors such as foreign supply and U.S.-China diplomacy, it is not always as simple as looking at current sales and growth to dictate long-term investing strategy.\nOne such example would beTaiwan Semiconductor Manufacturing (TSM).\nThe stock of Taiwan Semi, one of the world’s largest independent semiconductor foundries, has risen by 120% in the last year. But it may have reached peak valuation as more companies making similar products come onto the market. According to a research report from World Semiconductor Trade Statistic, the global semiconductor market is projected to grow by 19.71% to $527 billion in 2021.\n“I think that we're going to see a significant increase in chip manufacturing and that's going to lead to some incredible opportunities, especially in some of these ancillary players,” Quint Tatro, the chief investment officer of advisory firm Joule Financial , told TheStreet. “Companies will meet the demand and start pumping out chips like no other.”\nGlobally, there are now more than 750 companies making semiconductors - other strong players include NXP Semiconductors (NXPI), Applied Materials (AMAT) and KLA (KLAC). In the United States, Intel (INTC) and Qualcomm (QCOM) have been making semiconductor technology for decades. Globally, Asia Pacific dominates with more than 60% of the world’s sales.\nBut while the spotlight is currently on those that actually make semiconductors, ancillary products are just as necessary to ramp up manufacturing while treated like a secondary investment. According to Tatro, investors should be keeping a close eye on Axcelis Technologies(ACLS) -Get Report, a Massachusetts-based company from which Taiwan Semiconductor buys its manufacturing equipment. He said that the company compounded its book value at over 16% over the last five years while trading at a multiple of 15, a cheap investment given its potential for growth.\n“If you think of Taiwan Semiconductor’s [manufacturing plans], they’re going to need increased fabrication equipment to actually produce the semiconductors,” Tatro said. “Our belief is that we will see a ramp-up in orders for Axcelis fabrication equipment that will benefit the company greatly.”\nAnother is the Taiwan-based mCore Technology, which specializes in the packaging that surrounds the semiconductor chips. Tatro explained that after receiving the semiconductors from Taiwan Semiconductor, Intel and Apple (AAPL) -Get Report, the company packages them in a way that makes them ready to enter a product like a computer. Surging demand means that the company's revenue grew 25% year over year while net income increased by almost 200%.\nAnother option is Ultra Clean Holdings (UCTT), which creates tools and subsystems for the semiconductor.\n“Similarly to Axcelis, mCore should be an absolute benefactor from the increase in manufacturing in growing revenue,” Tatro said. “[…] They've got about 42% debt to equity so it's a little more debt than that I'd like to see but they have strong cash flows and we believe that with a forward multiple of under 11, this company is undervalued and poised for this sort of ancillary ramp-up in manufacturing.”\nDefiance ETFs co-founder and chief investment officer, Sylvia Jablonski, said other lesser-known names are Qorvo (QRVO) -Get Report, whose growth likely will be very strong as more of the wireless industry transitions to the 5G technology in which the company specializes.\nMaxLinear (MXL) -Get Report and GCP Applied Technologies (GCP) -Get Report are fast approaching major breakthrough in profitability while companies like Texas Instruments (TXN) -Get Report are valuable because they have their own foundries and will be protected from global shortages.\n“All of these companies make the list for me because they are pretty much in the ideal situation for constructing the basic equipment to deploy the 5G technology,” Jablonski told TheStreet.\n“Any company that is linked to that is going to experience healthier profit margins,” Jablonski added.\nInvestors whose only knowledge of semiconductors comes from the current investment buzz may also consider starting out with an ETF, Jablonski advised. Along with her company’s 5G ETF (FIVG), VanEck Vectors Semiconductor ET (SMH) and iShares Semiconductor ETF (SOXX) include both major players and less-talked-about companies like Entegris (ENTG) and ASE Technology (ASX) .\nBy dipping one’s toes with broad-based exposure to the industry, potential investors will be able to track the different holdings and have a better understanding of individual companies to watch out for.\nBut overall, Jablonski said that picking the right company is less important than getting into the industry generally. The chip shortage is not going anywhere soon and, with data from the Semiconductor Industry Association showing that a finished chip can take up to 26 weeks to manufacture, the investment opportunities should remain strong for at least the next five years.\n\"There's been a lot of talk by (President) Biden about the 5G infrastructure package and connecting rural and urban America,” Jablonski said.\n“A lot of the companies that allow all that to happen are semiconductor companies. There is no machine-to-machine communication, no automation processing, no AI or any of the other massive innovations in our future without semiconductors,\" Jablonski said.","news_type":1,"symbols_score_info":{"TSM":0.9,"MXL":0.9,"TXN":0.9,"INTC":0.9,"KLAC":0.9,"NXPI":0.9,"UCTT":0.9,"FIVG":0.9,"ENTG":0.9,"QRVO":0.9,"AMAT":0.9,"ACLS":0.9,"SOXX":0.9,"ASX":0.9,"GCP":0.9,"QCOM":0.9,"SMH":0.9}},"isVote":1,"tweetType":1,"viewCount":2207,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"defaultTab":"posts","isTTM":true}